SIRT5-Mediated Lysine Desuccinylation Impacts Diverse Metabolic Pathways

Molecular Cell

Volumn 50, Issue 6, 2013, Pages 919-930

  Park, Jeongsoon ^a   Chen, Yue ^c   Tishkoff, Daniel X ^a,e   Peng, Chao ^c   Tan, Minjia ^c,d   Dai, Lunzhai ^c   Xie, Zhongyu ^c   Zhang, Yi ^d   Zwaans, Bernadette M M ^a   Skinner, Mary E ^a   Lombard, David B ^a,b   Zhao, Yingming ^c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^e Emergent Biosolutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSINE; MALONIC ACID; PYRUVATE DEHYDROGENASE; SIRTUIN 5; SUCCINATE DEHYDROGENASE; SUCCINIC ACID;

ACETYLATION; AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL RESPIRATION; CELLULAR DISTRIBUTION; CITRIC ACID CYCLE; CONTROLLED STUDY; DESUCCINYLATION; ENZYME REGULATION; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS; STOICHIOMETRY; SUCCINYLATION;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; CELL RESPIRATION; CELLS, CULTURED; CONSENSUS SEQUENCE; GLYCOSYLATION; KINETICS; LYSINE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MOLECULAR SEQUENCE ANNOTATION; PROTEIN INTERACTION MAPS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTEOME; PYRUVATE DEHYDROGENASE COMPLEX; SIRTUINS; SUCCINATE DEHYDROGENASE;

EID: 84880791239     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.06.001     Document Type: Article

References (62)

1. Acker M.G., Bowers A.A., Walsh C.T. Generation of thiocillin variants by prepeptide gene replacement and invivo processing by Bacillus cereus. J.Am. Chem. Soc. 2009, 131:17563-17565.
2. Bader G.D., Hogue C.W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003, 4:2.
3. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
4. Cervera A.M., Bayley J.P., Devilee P., McCreath K.J. Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells. Mol. Cancer 2009, 8:89.
5. Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R., Peng J., Gu W., Zhao Y. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 2007, 6:812-819.
6. Chen Y., Zhao W., Yang J.S., Cheng Z., Luo H., Lu Z., Tan M., Gu W., Zhao Y. Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol. Cell. Proteomics 2012, 11:1048-1062.
7. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
8. Du J., Zhou Y., Su X., Yu J.J., Khan S., Jiang H., Kim J., Woo J., Kim J.H., Choi B.H., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
9. Finkel T., Deng C.X., Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature 2009, 460:587-591.
10. Finley L.W., Carracedo A., Lee J., Souza A., Egia A., Zhang J., Teruya-Feldstein J., Moreira P.I., Cardoso S.M., Clish C.B., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 2011, 19:416-428.
11. Gao X., Wang H., Yang J.J., Liu X., Liu Z.R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 2012, 45:598-609.
12. Gill A.J. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology 2012, 44:285-292.
13. Hallows W.C., Yu W., Smith B.C., Devries M.K., Ellinger J.J., Someya S., Shortreed M.R., Prolla T., Markley J.L., Smith L.M., et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 2011, 41:139-149.
14. Hao H.X., Khalimonchuk O., Schraders M., Dephoure N., Bayley J.P., Kunst H., Devilee P., Cremers C.W., Schiffman J.D., Bentz B.G., et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009, 325:1139-1142.
15. Hebert A.S., Dittenhafer-Reed K.E., Yu W., Bailey D.J., Selen E.S., Boersma M.D., Carson J.J., Tonelli M., Balloon A.J., Higbee A.J., et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 2013, 49:186-199.
16. Hirschey M.D., Shimazu T., Huang J.Y., Schwer B., Verdin E. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:267-277.
17. Jensen L.J., Kuhn M., Stark M., Chaffron S., Creevey C., Muller J., Doerks T., Julien P., Roth A., Simonovic M., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009, 37(Database issue):D412-D416.
18. Jeoung N.H., Sanghani P.C., Zhai L., Harris R.A. Assay of the pyruvate dehydrogenase complex by coupling with recombinant chicken liver arylamine N-acetyltransferase. Anal. Biochem. 2006, 356:44-50.
19. Kawai Y., Fujii H., Okada M., Tsuchie Y., Uchida K., Osawa T. Formation of Nepsilon-(succinyl)lysine invivo: a novel marker for docosahexaenoic acid-derived protein modification. J.Lipid Res. 2006, 47:1386-1398.
20. Kendrick A.A., Choudhury M., Rahman S.M., McCurdy C.E., Friederich M., Van Hove J.L., Watson P.A., Birdsey N., Bao J., Gius D., et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem. J. 2011, 433:505-514.
21. Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T., Kho Y., Xiao H., Xiao L., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
22. Korpershoek E., Favier J., Gaal J., Burnichon N., van Gessel B., Oudijk L., Badoual C., Gadessaud N., Venisse A., Bayley J.P., et al. SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J.Clin. Endocrinol. Metab. 2011, 96:E1472-E1476.
23. Kranendijk M., Struys E.A., van Schaftingen E., Gibson K.M., Kanhai W.A., van der Knaap M.S., Amiel J., Buist N.R., Das A.M., de Klerk J.B., et al. IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science 2010, 330:336.
24. Lian C.G., Xu Y., Ceol C., Wu F., Larson A., Dresser K., Xu W., Tan L., Hu Y., Zhan Q., et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-1146.
25. Lombard D.B., Alt F.W., Cheng H.L., Bunkenborg J., Streeper R.S., Mostoslavsky R., Kim J., Yancopoulos G., Valenzuela D., Murphy A., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27:8807-8814.
26. Lombard D.B., Tishkoff D.X., Zwaans B.M. Mitochondrial regulation by protein acetylation. Mitochondrial Signaling in Health and Disease 2012, 269-298. Taylor and Francis, London. E. Cadenas, S. Orrenius, L. Packer (Eds.).
27. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
28. Morten K.J., Beattie P., Brown G.K., Matthews P.M. Dichloroacetate stabilizes the mutant E1alpha subunit in pyruvate dehydrogenase deficiency. Neurology 1999, 53:612-616.
29. Nadanaciva S., Bernal A., Aggeler R., Capaldi R., Will Y. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol. InVitro 2007, 21:902-911.
30. Nakagawa T., Lomb D.J., Haigis M.C., Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
31. Nakamura Y., Ogura M., Ogura K., Tanaka D., Inagaki N. SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice. FEBS Lett. 2012, 586:4076-4081.
32. Neumann H.P., Pawlu C., Peczkowska M., Bausch B., McWhinney S.R., Muresan M., Buchta M., Franke G., Klisch J., Bley T.A., et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943-951. European-American Paraganglioma Study Group.
33. Niemann S., Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 2000, 26:268-270.
34. Ogura M., Nakamura Y., Tanaka D., Zhuang X., Fujita Y., Obara A., Hamasaki A., Hosokawa M., Inagaki N. Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem. Biophys. Res. Commun. 2010, 393:73-78.
35. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 2010, 3:ra3.
36. Oudijk L., Gaal J., Korpershoek E., van Nederveen F.H., Kelly L., Schiavon G., Verweij J., Mathijssen R.H., den Bakker M.A., Oldenburg R.A., et al. SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors. Mod. Pathol. 2013, 26:456-463.
37. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
38. Patel M.S., Korotchkina L.G. Regulation of the pyruvate dehydrogenase complex. Biochem. Soc. Trans. 2006, 34:217-222.
39. Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y., He W., Yang K., et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics 2011, 10. M111 012658.
40. Pollard P., Wortham N., Barclay E., Alam A., Elia G., Manek S., Poulsom R., Tomlinson I. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J.Pathol. 2005, 205:41-49.
41. Ricketts C., Woodward E.R., Killick P., Morris M.R., Astuti D., Latif F., Maher E.R. Germline SDHB mutations and familial renal cell carcinoma. J.Natl. Cancer Inst. 2008, 100:1260-1262.
42. Ricketts C.J., Forman J.R., Rattenberry E., Bradshaw N., Lalloo F., Izatt L., Cole T.R., Armstrong R., Kumar V.K., Morrison P.J., et al. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum. Mutat. 2010, 31:41-51.
43. Rosen R., Becher D., Büttner K., Biran D., Hecker M., Ron E.Z. Probing the active site of homoserine trans-succinylase. FEBS Lett. 2004, 577:386-392.
44. Ruepp A., Brauner B., Dunger-Kaltenbach I., Frishman G., Montrone C., Stransky M., Waegele B., Schmidt T., Doudieu O.N., Stümpflen V., Mewes H.W. CORUM: the comprehensive resource of mammalian protein complexes. Nucleic Acids Res. 2008, 36(Database issue):D646-D650.
45. Schlicker C., Gertz M., Papatheodorou P., Kachholz B., Becker C.F., Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J.Mol. Biol. 2008, 382:790-801.
46. Schwab M.A., Kölker S., van den Heuvel L.P., Sauer S., Wolf N.I., Rating D., Hoffmann G.F., Smeitink J.A., Okun J.G. Optimized spectrophotometric assay for the completely activated pyruvate dehydrogenase complex in fibroblasts. Clin. Chem. 2005, 51:151-160.
47. Schwer B., Eckersdorff M., Li Y., Silva J.C., Fermin D., Kurtev M.V., Giallourakis C., Comb M.J., Alt F.W., Lombard D.B. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8:604-606.
48. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
49. Smith E.H., Janknecht R., Maher L.J. Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum. Mol. Genet. 2007, 16:3136-3148.
50. Smith B.C., Settles B., Hallows W.C., Craven M.W., Denu J.M. SIRT3 substrate specificity determined by peptide arrays and machine learning. ACS Chem. Biol. 2011, 6:146-157.
51. Stacpoole P.W., Kurtz T.L., Han Z., Langaee T. Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Adv. Drug Deliv. Rev. 2008, 60:1478-1487.
52. Starai V.J., Celic I., Cole R.N., Boeke J.D., Escalante-Semerena J.C. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 2002, 298:2390-2392.
53. Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T., Cheng Z., Rousseaux S., Rajagopal N., et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
54. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
55. Wang Q., Zhang Y., Yang C., Xiong H., Lin Y., Yao J., Li H., Xie L., Zhao W., Yao Y., et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 2010, 327:1004-1007.
56. Wieland O.H., Patzelt C., Löffler G. Active and inactive forms of pyruvate dehydrogenase in rat liver. Effect of starvation and refeeding and of insulin treatment on pyruvate-dehydrogenase interconversion. Eur. J. Biochem. 1972, 26:426-433.
57. Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y. Lysine succinylation and lysine malonylation in histones. Mol. Cell. Proteomics 2012, 11:100-107.
58. Yang W., Xia Y., Hawke D., Li X., Liang J., Xing D., Aldape K., Hunter T., Alfred Yung W.K., Lu Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012, 150:685-696.
59. Yen K.E., Bittinger M.A., Su S.M., Fantin V.R. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 2010, 29:6409-6417.
60. Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F., Grishin N.V., Zhao Y. Lysine acetylation is a highly abundant and evolutionarily conserved modification in Escherichia coli. Mol. Cell. Proteomics 2009, 8:215-225.
61. Zhang Z., Tan M., Xie Z., Dai L., Chen Y., Zhao Y. Identification of lysine succinylation as a new post-translational modification. Nat. Chem. Biol. 2011, 7:58-63.
62. Zhao S., Xu W., Jiang W., Yu W., Lin Y., Zhang T., Yao J., Zhou L., Zeng Y., Li H., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.